Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism SDH2 inhibitors(Mitochondrial complex II; succinate dehydrogenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 3 | US | 03 Nov 2020 | |
Non-Small Cell Lung Cancer | Preclinical | US | 08 Apr 2024 | |
Non-Small Cell Lung Cancer | Preclinical | US | 08 Apr 2024 |